Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.98
+0.08 (0.67%)
Feb 4, 2026, 3:00 PM CST

SHA:603439 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,7352,1441,6341,201938.84630.15
Other Revenue
0.550.550.510.330.130.08
1,7362,1441,6351,201938.97630.22
Revenue Growth (YoY)
-17.84%31.16%36.10%27.94%48.99%-28.69%
Cost of Revenue
533.89652.98437.99339.52277.07208.98
Gross Profit
1,2021,4911,197861.8661.89421.25
Selling, General & Admin
972.891,089879.21618.01492.75304.23
Research & Development
36.0646.530.6117.867.685.63
Other Operating Expenses
17.1317.3116.611.018.565.38
Operating Expenses
1,0241,163929.77657.18509.98316.38
Operating Income
178.1328.34267.22204.62151.92104.87
Interest Expense
-11.82-14.61-4.13-5.24-8.34-2.2
Interest & Investment Income
2.965.860.1317.5625.817.69
Other Non Operating Income (Expenses)
5.79-0.371.89-0.21-0.09-0.08
EBT Excluding Unusual Items
175.03319.16325.1216.74169.29110.28
Impairment of Goodwill
----0.08--
Gain (Loss) on Sale of Investments
-2.840.15--0.09--
Gain (Loss) on Sale of Assets
0.09-0.170.59-0.09-0.15-
Asset Writedown
-1.02-0.57-0.05-0.1-0.01-
Other Unusual Items
13.156.478.386.187.51-0.38
Pretax Income
184.41325.03334.02222.56176.65109.9
Income Tax Expense
19.6845.1939.1530.6228.0515.95
Earnings From Continuing Operations
164.73279.84294.87191.94148.693.95
Minority Interest in Earnings
-4.05-5.81-2.179.353.680
Net Income
160.68274.03292.7201.28152.2893.95
Net Income to Common
160.68274.03292.7201.28152.2893.95
Net Income Growth
-51.14%-6.38%45.42%32.18%62.08%-29.40%
Shares Outstanding (Basic)
402409412411412391
Shares Outstanding (Diluted)
402409412411412391
Shares Change (YoY)
-3.85%-0.79%0.36%-0.19%5.14%5.90%
EPS (Basic)
0.400.670.710.490.370.24
EPS (Diluted)
0.400.670.710.490.370.24
EPS Growth
-49.19%-5.63%44.90%32.43%54.17%-33.33%
Free Cash Flow
37.361.87167.97173.38128.9611.54
Free Cash Flow Per Share
0.090.150.410.420.310.03
Dividend Per Share
0.3400.3400.2000.100-0.250
Dividend Growth
70.00%70.00%100.00%---
Gross Margin
69.24%69.55%73.21%71.74%70.49%66.84%
Operating Margin
10.26%15.31%16.34%17.03%16.18%16.64%
Profit Margin
9.26%12.78%17.90%16.75%16.22%14.91%
Free Cash Flow Margin
2.15%2.89%10.27%14.43%13.73%1.83%
EBITDA
280.21402.3303.64220.44163.09112.98
EBITDA Margin
16.14%18.76%18.57%18.35%17.37%17.93%
D&A For EBITDA
102.1173.9636.4215.8211.178.11
EBIT
178.1328.34267.22204.62151.92104.87
EBIT Margin
10.26%15.31%16.34%17.03%16.18%16.64%
Effective Tax Rate
10.67%13.90%11.72%13.76%15.88%14.51%
Revenue as Reported
1,7362,1441,6351,201938.97630.22
Advertising Expenses
-1.471.782.290.010
Source: S&P Global Market Intelligence. Standard template. Financial Sources.